Evolution of the Average Target: MakeMyTrip Limited

Evolution of the Target Price: MakeMyTrip Limited

Changes in Analyst Recommendations: MakeMyTrip Limited

b553cb31e.CBOBVTa81s4ijsRo2wdbW6U08nyN5MxPNYiBeu5rZOw.PlXeGVfkgZoUt4FFvn8aLshRhxq5prYQRfrxD7smU68_fc4HVYTgqWXFrw~94c01d6c823a13225a847b70166e4940
03-30 Morpheus Research says it holds short positions in MakeMyTrip RE
01-22 Morgan Stanley Trims Price Target on MakeMyTrip to $106 From $113, Keeps Overweight Rating MT
01-21 Citigroup Lowers MakeMyTrip's Price Target to $96 from $108, Keeps Buy Rating MT
11-17 CICC Initiates MakeMyTrip at Outperform With $95 Price Target MT
25-06-24 Macquarie Upgrades MakeMyTrip to Outperform From Neutral, $110 Price Target MT
24-02-21 Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Adjusts Price Target to $60 From $50 MT
24-02-21 Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Raises Price Target to $60 From $50 MT
23-12-26 Citigroup Raises Price Target on MakeMyTrip to $54 From $47, Maintains Buy Rating MT
23-08-02 Citigroup Adjusts Price Target on MakeMyTrip to $45 From $43, Maintains Buy Rating MT
22-12-08 Morgan Stanley Upgrades MakeMyTrip to Overweight From Equalweight, Price Target is $36 MT
22-10-04 UBS Adjusts MakeMyTrip Price Target to $40 From $37, Maintains Buy Rating MT
22-09-14 JPMorgan Starts MakeMyTrip at Overweight With $44 Price Target MT
22-08-31 Macquarie Starts MakeMyTrip at Outperform With $42 Price Target MT
22-08-30 BofA Securities Upgrades MakeMyTrip to Buy from Neutral, Adjusts Price Target to $40 from $33 MT
22-06-13 UBS Double Upgrades MakeMyTrip to Buy From Sell on a Recovering Travel Market, Adjusts Price Target to $37 From $23 MT
22-05-26 Goldman Sachs Lifts Price Target for MakeMyTrip to $39 From $38, Maintains Buy Rating MT
22-05-26 Citigroup Adjusts MakeMyTrip's Price Target to $43 from $42, Keeps Buy Rating MT
22-02-24 Morgan Stanley Resumes Coverage of MakeMyTrip With Overweight Rating, $29 Price Target MT
21-07-28 MAKEMYTRIP : Citigroup Adjusts Price Target on MakeMyTrip to $38 From $34, Reiterates Buy Rating MT
21-06-01 MAKEMYTRIP : Ambit Capital Initiates Coverage on MakeMyTrip With Buy Rating, $37 Price Target MT
21-02-16 MAKEMYTRIP : BofA Securities Upgrades MakeMyTrip to Neutral From Underperform, Adjusts Price Target to $32 From $14 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.49%
+23.45%
+7.05%
+42.9%
+77.04%
+20.34%
-2.18%
+18.99%
+6.94%
+60.95%
Average +28.60%
Weighted average by Cap. +24.30%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
53.22USD
Average target price
71.27USD
Spread / Average Target
+33.92%
High Price Target
84.00USD
Spread / Highest target
+57.84%
Low Price Target
58.00USD
Spread / Lowest Target
+8.98%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
Citigroup
CICC Research
Macquarie
UBS
JPMorgan Chase
BofA Securities
Goldman Sachs
Ambit Capital
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
53.22USD
Average target price
71.27USD
Spread / Average Target
+33.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMYT Stock
  4. Consensus MakeMyTrip Limited